
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

